ADVANCED MALIGNANT SOLID TUMOR
Clinical trials for ADVANCED MALIGNANT SOLID TUMOR explained in plain language.
Never miss a new study
Get alerted when new ADVANCED MALIGNANT SOLID TUMOR trials appear
Sign up with your email to follow new studies for ADVANCED MALIGNANT SOLID TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug duo aims to shrink advanced tumors in phase 2 trial
Disease control Recruiting nowThis study tests two experimental drugs, MHB036C and MHB039A, given together to people with advanced breast cancer or other advanced solid tumors that have spread. The goal is to see if the combination can shrink tumors and how safe it is. About 210 adults aged 18 to 75 with meas…
Matched conditions: ADVANCED MALIGNANT SOLID TUMOR
Phase: PHASE2 • Sponsor: Minghui Pharmaceutical (Hangzhou) Ltd • Aim: Disease control
Last updated May 26, 2026 05:04 UTC
-
New hope for advanced cancer patients: experimental drug MHB009C enters human trials
Disease control Recruiting nowThis study is testing a new drug called MHB009C in 200 people with advanced solid tumors that have not responded to standard treatments. The goal is to find a safe dose and see if the drug can shrink tumors. Participants will receive the drug by IV and be closely monitored for si…
Matched conditions: ADVANCED MALIGNANT SOLID TUMOR
Phase: PHASE1, PHASE2 • Sponsor: Minghui Pharmaceutical (Hangzhou) Ltd • Aim: Disease control
Last updated May 26, 2026 05:01 UTC
-
New cancer drug PLT012 enters human testing – could it shrink tumors?
Disease control Recruiting nowThis early-stage study tests a new drug, PLT012, in 36 adults with advanced solid tumors that have not responded to other treatments. The main goal is to find safe doses and check for side effects. Researchers will also measure drug levels in the blood and see if tumors shrink. A…
Matched conditions: ADVANCED MALIGNANT SOLID TUMOR
Phase: PHASE1 • Sponsor: Pilatus Biosciences Inc • Aim: Disease control
Last updated May 26, 2026 04:38 UTC
-
New combo therapy targets Hard-to-Treat cancers
Disease control Recruiting nowThis study tests two experimental drugs, MHB088C and MHB039A, given together to adults with advanced solid tumors that have not responded to standard treatments. The goal is to find a safe dose and see if the combination can shrink tumors. About 116 participants will take part in…
Matched conditions: ADVANCED MALIGNANT SOLID TUMOR
Phase: PHASE1, PHASE2 • Sponsor: Minghui Pharmaceutical (Hangzhou) Ltd • Aim: Disease control
Last updated May 26, 2026 04:37 UTC
-
New drug MHB042C tested in advanced cancer patients
Disease control Recruiting nowThis study tests a new drug called MHB042C in about 200 adults with advanced solid tumors that have not responded to standard treatments. The goal is to find a safe dose and see if the drug can shrink tumors. Participants will receive the drug by IV and be closely monitored for s…
Matched conditions: ADVANCED MALIGNANT SOLID TUMOR
Phase: PHASE1, PHASE2 • Sponsor: Minghui Pharmaceutical (Hangzhou) Ltd • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
New immune therapy targets Hard-to-Treat cancers
Disease control Recruiting nowThis early-phase trial tests a new drug called RPTR-1-201, which helps the immune system attack cancer cells. It is for adults with advanced solid tumors that cannot be cured with standard treatments. The study will check safety and whether the drug shrinks tumors, both alone and…
Matched conditions: ADVANCED MALIGNANT SOLID TUMOR
Phase: PHASE1, PHASE2 • Sponsor: Repertoire Immune Medicines • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
Modified virus takes on Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis early-stage study tests a new treatment called VG2062, a modified virus designed to attack cancer cells. It is for 30 adults with advanced solid tumors that have not responded to standard therapies. The main goals are to check safety and find the best dose for future studies…
Matched conditions: ADVANCED MALIGNANT SOLID TUMOR
Phase: PHASE1 • Sponsor: Shanghai Virogin Biotech Co., Ltd. • Aim: Disease control
Last updated May 19, 2026 11:47 UTC
-
New hope for advanced cancer: experimental drug MHB048C enters human trials
Disease control Recruiting nowThis study tests a new drug called MHB048C in people with advanced solid tumors that have not responded to standard treatments. The goal is to find a safe dose and see if it can shrink tumors. About 200 adults will take part in this early-phase trial.
Matched conditions: ADVANCED MALIGNANT SOLID TUMOR
Phase: PHASE1, PHASE2 • Sponsor: Minghui Pharmaceutical (Hangzhou) Ltd • Aim: Disease control
Last updated May 18, 2026 12:05 UTC